Video Forum: Brian McNamara and Lisa Paley, Haleon
This week’s Video Forum features two leaders of the newly minted Haleon.
This week’s Video Forum features two leaders of the newly minted Haleon.
It is easy for those who are not health care professionals to overlook the tremendous potential for innovation in our field today. Similarly, anyone who is not a health policy wonk might not see the important ways policy is evolving to improve the delivery of care for millions of patients.
The pharmacy profession and patient care services delivered by the pharmacy team have evolved significantly over the past few years, bringing new opportunities and challenges.
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Dimethyl Fumarate Delayed-Release Capsules, 120mg and 240mg.
A contentious midterm election is behind us, and while pundits and other experts argue about what the results mean, those of us who deeply care about sound health care policy can hope for a new year where solid evidence and the quest for transparent information matters at least as much as political
Bausch + Lomb Corp. announced the U.S. introduction of PreserVision AREDS 2 Formula mini soft gels with OCUSorb. This product is the only AREDS 2 eye vitamin with the OCUSorb formulation.
New, exciting trends are emerging in community pharmacy practice, but what’s past is still prologue. Sal D’Angelo, a past president of the National Community Pharmacists Association/National Association of Retail Druggists, was the first person I heard say, “Get into politics or get out of pharmacy.
pharmaceutical and commercial — has become even more evident amid the COVID-19 pandemic. These are among the many reasons why today is both an exciting and challenging time to practice
As we welcome 2023 and the beginning of the 118th Congress, HDA pharmaceutical distributor members’ role as a convener within the health care ecosystem will be more important than ever.
Rite Aid Corp. announced Monday that its board of directors has appointed Elizabeth (“Busy”) Burr, a member of the company’s board, as interim CEO, effective immediately. Burr’s appointment follows Heyward Donigan’s departure from the company as president and CEO, and as a member of the board.
Top chain drug and distribution executives give their outlook for 2023 on the following pages, detailing the challenges and opportunities that lie ahead for the industry.
The future of health care in this country will center on ecosystems that span the continuum of care. A number of entities, including companies with roots in chain pharmacy, are in the process of altering their business model to align with the new paradigm. None of them is further along in assembling
ALEXANDRIA, Va. – The Pharmacy Quality Alliance (PQA) has expanded the PQA Social Determinants of Health (SDOH) Resource Guide. The second edition of this guide profiles 32 SDOH services, including 12 new services and updates to nine initiatives from the first edition.
An article by McKinsey & Co. describes the current era with the words: “Return, Reimagine, Reinvent.” I cannot think of better positioning for our industry and for NACDS specifically in the association’s 90th Anniversary year. Our industry can look at the word “Return” from two angles.
No one knows for certain what the new year will bring for chain pharmacy operators.